This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akutsu T, Ito E, Narita M, Ohdaira H, Suzuki Y, Urashima M (2020) Effect of serum SPARC levels on survival in patients with digestive tract cancer: a post hoc analysis of the AMATERASU randomized clinical trial. Cancers (Basel) 12(6):1465. https://doi.org/10.3390/cancers12061465
Allen DL, Cleary AS, Speaker KJ, Lindsay SF, Uyenishi J, Reed JM, Madden MC, Mehan RS (2008) Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice. Am J Physiol Metab 294(5):E918–E927. https://doi.org/10.1152/ajpendo.00798.2007
Ando K, Takahashi F, Motojima S, Nakashima K, Kaneko N, Hoshi K, Takahashi K (2013) Possible role for tocilizumab, an anti–Interleukin-6 receptor antibody, in treating cancer cachexia. J Clin Oncol 31(6):e69–e72. https://doi.org/10.1200/JCO.2012.44.2020
Aoi W, Naito Y, Takagi T, Tanimura Y, Takanami Y, Kawai Y, Sakuma K, Hang LP, Mizushima K, Hirai Y, Koyama R, Wada S, Higashi A, Kokura S, Ichikawa H, Yoshikawa T (2013) A novel myokine, secreted protein acidic and rich in cysteine (SPARC), suppresses colon tumorigenesis via regular exercise. Gut 62(6):882–889. https://doi.org/10.1136/gutjnl-2011-300776
Aoyagi T, Terracina KP, Raza A, Matsubara H, Takabe K (2015) Cancer cachexia, mechanism and treatment. World J Gastrointest Oncol 7(4):17. https://doi.org/10.4251/wjgo.v7.i4.17
Arany Z, Foo S-Y, Ma Y, Ruas JL, Bommi-Reddy A, Girnun G, Cooper M, Laznik D, Chinsomboon J, Rangwala SM, Baek KH, Rosenzweig A, Spiegelman BM (2008) HIF-independent regulation of VEGF and angiogenesis by the transcriptional coactivator PGC-1α. Nature 451(7181):1008–1012. https://doi.org/10.1038/nature06613
Argilés JM (2017) The 2015 ESPEN Sir David Cuthbertson lecture: inflammation as the driving force of muscle wasting in cancer. Clin Nutr 36(3):798–803. https://doi.org/10.1016/j.clnu.2016.05.010
Argiles JM, Lopez-Soriano FJ, Busquets S (2012) Counteracting inflammation: a promising therapy in cachexia. Crit Rev Oncog 17(3):253–262. https://doi.org/10.1615/CritRevOncog.v17.i3.30
Argilés JM, Stemmler B, López-Soriano FJ, Busquets S (2019) Inter-tissue communication in cancer cachexia. Nat Rev Endocrinol 15(1):9–20. https://doi.org/10.1038/s41574-018-0123-0
Arthur ST, Van Doren BA, Roy D, Noone JM, Zacherle E, Blanchette CM (2016) Cachexia among US cancer patients. J Med Econ 19(9):874–880. https://doi.org/10.1080/13696998.2016.1181640
Aversa Z, Bonetto A, Penna F, Costelli P, Di Rienzo G, Lacitignola A, Baccino FM, Ziparo V, Mercantini P, Rossi Fanelli F, Muscaritoli M (2012) Changes in Myostatin signaling in non-weight-losing cancer patients. Ann Surg Oncol 19(4):1350–1356. https://doi.org/10.1245/s10434-011-1720-5
Baghy K, Reszegi A, Tátrai P, Kovalszky I (2020) Decorin in the tumor microenvironment. In: Advances in experimental medicine and biology. Springer, pp 17–38
Barra NG, Reid S, MacKenzie R, Werstuck G, Trigatti BL, Richards C, Holloway AC, Ashkar AA (2010) Interleukin-15 contributes to the regulation of murine adipose tissue and human adipocytes. Obesity 18(8):1601–1607. https://doi.org/10.1038/oby.2009.445
Barra NG, Palanivel R, Denou E, Chew MV, Gillgrass A, Walker TD, Kong J, Richards CD, Jordana M, Collins SM, Trigatti BL, Holloway AC, Raha S, Steinberg GR, Ashkar AA (2014) Interleukin-15 modulates adipose tissue by altering mitochondrial mass and activity. PLoS One 9(12):e114799. https://doi.org/10.1371/journal.pone.0114799
Baumeister SE, Schlesinger S, Aleksandrova K, Jochem C, Jenab M, Gunter MJ, Overvad K, Tjønneland A, Boutron-Ruault M-C, Carbonnel F, Fournier A, Kühn T, Kaaks R, Pischon T, Boeing H, Trichopoulou A, Bamia C, La Vecchia C, Masala G, Panico S, Fasanelli F, Tumino R, Grioni S, Bueno de Mesquita B, Vermeulen R, May AM, Borch KB, Oyeyemi SO, Ardanaz E, Rodríguez-Barranco M, Dolores Chirlaque López M, Felez-Nobrega M, Sonestedt E, Ohlsson B, Hemmingsson O, Werner M, Perez-Cornago A, Ferrari P, Stepien M, Freisling H, Tsilidis KK, Ward H, Riboli E, Weiderpass E, Leitzmann MF (2019) Association between physical activity and risk of hepatobiliary cancers: a multinational cohort study. J Hepatol 70(5):885–892. https://doi.org/10.1016/j.jhep.2018.12.014
Bekki M, Hashida R, Kawaguchi T, Goshima N, Yoshiyama T, Otsuka T, Koya S, Hirota K, Matsuse H, Niizeki T, Torimura T, Shiba N (2018) The association between sarcopenia and decorin, an exercise-induced myokine, in patients with liver cirrhosis: a pilot study. JCSM Rapid Commun 1(2):1–10. https://doi.org/10.1002/j.2617-1619.2018.tb00009.x
Bo S, Dianliang Z, Hongmei Z, Xinxiang W, Yanbing Z, Xiaobo L (2010) Association of interleukin-8 gene polymorphism with cachexia from patients with gastric cancer. J Interf Cytokine Res 30(1):9–14. https://doi.org/10.1089/jir.2009.0007
Bobadilla M, Sainz N, Abizanda G, Orbe J, Rodriguez JA, Páramo JA, Prósper F, Pérez-Ruiz A (2014) The CXCR4/SDF1 axis improves muscle regeneration through MMP-10 activity. Stem Cells Dev 23(12):1417–1427. https://doi.org/10.1089/scd.2013.0491
Bohlen J, McLaughlin SL, Hazard-Jenkins H, Infante AM, Montgomery C, Davis M, Pistilli EE (2018) Dysregulation of metabolic-associated pathways in muscle of breast cancer patients: preclinical evaluation of interleukin-15 targeting fatigue. J Cachexia Sarcopenia Muscle 9(4):701–714. https://doi.org/10.1002/jcsm.12294
Bonetto A, Penna F, Minero V, Reffo P, Bonelli G, Baccino F, Costelli P (2009) Deacetylase inhibitors modulate the Myostatin/Follistatin axis without improving cachexia in tumor-bearing mice. Curr Cancer Drug Targets 9(5):608–616. https://doi.org/10.2174/156800909789057015
Bordignon C, dos Santos BS, Rosa DD (2022) Impact of cancer cachexia on cardiac and skeletal muscle: role of exercise training. Cancers (Basel) 14(2):342. https://doi.org/10.3390/cancers14020342
Boström P, Wu J, Jedrychowski MP, Korde A, Ye L, Lo JC, Rasbach KA, Boström EA, Choi JH, Long JZ, Kajimura S, Zingaretti MC, Vind BF, Tu H, Cinti S, Højlund K, Gygi SP, Spiegelman BM (2012) A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481(7382):463–468. https://doi.org/10.1038/nature10777
Bruun JM, Lihn AS, Madan AK, Pedersen SB, Schiøtt KM, Fain JN, Richelsen B (2004) Higher production of IL-8 in visceral vs. subcutaneous adipose tissue. Implication of nonadipose cells in adipose tissue. Am J Physiol Metab 286(1):E8–E13. https://doi.org/10.1152/ajpendo.00269.2003
Busquets S, Toledo M, Orpí M, Massa D, Porta M, Capdevila E, Padilla N, Frailis V, López-Soriano FJ, Han HQ, Argilés JM (2012) Myostatin blockage using actRIIB antagonism in mice bearing the Lewis lung carcinoma results in the improvement of muscle wasting and physical performance. J Cachexia Sarcopenia Muscle 3(1):37–43. https://doi.org/10.1007/s13539-011-0049-z
Carbó N, López-Soriano J, Costelli P, Busquets S, Alvarez B, Baccino FM, Quinn LS, López-Soriano FJ, Argilés JM (2000) Interleukin-15 antagonizes muscle protein waste in tumour-bearing rats. Br J Cancer 83(4):526–531. https://doi.org/10.1054/bjoc.2000.1299
Carson JA, Baltgalvis KA (2010) Interleukin 6 as a key regulator of muscle mass during cachexia. Exerc Sport Sci Rev 38(4):168–176. https://doi.org/10.1097/JES.0b013e3181f44f11
Cleasby ME, Jarmin S, Eilers W, Elashry M, Andersen DK, Dickson G, Foster K (2014) Local overexpression of the myostatin propeptide increases glucose transporter expression and enhances skeletal muscle glucose disposal. Am J Physiol Metab 306(7):E814–E823. https://doi.org/10.1152/ajpendo.00586.2013
Coletta AM, Agha NH, Baker FL, Niemiro GM, Mylabathula PL, Brewster AM, Bevers TB, Fuentes-Mattei E, Basen-Engquist K, Gilchrist SC, Simpson RJ (2021) The impact of high-intensity interval exercise training on NK-cell function and circulating myokines for breast cancer prevention among women at high risk for breast cancer. Breast Cancer Res Treat 187(2):407–416. https://doi.org/10.1007/s10549-021-06111-z
Coletti D (2018) Chemotherapy-induced muscle wasting: an update. Eur J Trans Myol 28(2). https://doi.org/10.4081/ejtm.2018.7587
Conlon KC, Lugli E, Welles HC, Rosenberg SA, Fojo AT, Morris JC, Fleisher TA, Dubois SP, Perera LP, Stewart DM, Goldman CK, Bryant BR, Decker JM, Chen J, Worthy TA, Figg WD, Peer CJ, Sneller MC, Lane HC, Yovandich JL, Creekmore SP, Roederer M, Waldmann TA (2015) Redistribution, hyperproliferation, activation of natural killer cells and CD8 T cells, and cytokine production during first-in-human clinical trial of recombinant human interleukin-15 in patients with cancer. J Clin Oncol 33(1):74–82. https://doi.org/10.1200/JCO.2014.57.3329
Costelli P, Muscaritoli M, Bonetto A, Penna F, Reffo P, Bossola M, Bonelli G, Doglietto GB, Baccino FM, Fanelli FR (2008) Muscle myostatin signalling is enhanced in experimental cancer cachexia. Eur J Clin Investig 38(7):531–538. https://doi.org/10.1111/j.1365-2362.2008.01970.x
Daou HN (2020) Exercise as an anti-inflammatory therapy for cancer cachexia: a focus on interleukin-6 regulation. Am J Physiol Integr Comp Physiol 318(2):R296–R310. https://doi.org/10.1152/ajpregu.00147.2019
de Castro GS, Simoes E, Lima JDCC, Ortiz-Silva M, Festuccia WT, Tokeshi F, Alcântara PS, Otoch JP, Coletti D, Seelaender M (2019) Human cachexia induces changes in mitochondria, autophagy and apoptosis in the skeletal muscle. Cancers (Basel) 11(9):1264. https://doi.org/10.3390/cancers11091264
de Castro GS, Correia-Lima J, Simoes E, Orsso CE, Xiao J, Gama LR, Gomes SP, Gonçalves DC, Costa RGF, Radloff K, Lenz U, Taranko AE, Bin FC, Formiga FB, de Godoy LGL, de Souza RP, Nucci LHA, Feitoza M, de Castro CC, Tokeshi F, Alcantara PSM, Otoch JP, Ramos AF, Laviano A, Coletti D, Mazurak VC, Prado CM, Seelaender M (2021) Myokines in treatment-naïve patients with cancer-associated cachexia. Clin Nutr 40(4):2443–2455. https://doi.org/10.1016/j.clnu.2020.10.050
Deans C, Wigmore SJ (2005) Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care 8(3):265–269. https://doi.org/10.1097/01.mco.0000165004.93707.88
Demontis F, Piccirillo R, Goldberg AL, Perrimon N (2013) The influence of skeletal muscle on systemic aging and lifespan. Aging Cell 12(6):943–949. https://doi.org/10.1111/acel.12126
Dewys WD, Begg C, Lavin PT, Band PR, Bennett JM, Bertino JR, Cohen MH, Douglass HO, Engstrom PF, Ezdinli EZ, Horton J, Johnson GJ, Moertel CG, Oken MM, Perlia C, Rosenbaum C, Silverstein MN, Skeel RT, Sponzo RW, Tormey DC (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am J Med 69(4):491–497. https://doi.org/10.1016/S0149-2918(05)80001-3
Evans WJ, Morley JE, Argilés J, Bales C, Baracos V, Guttridge D, Jatoi A, Kalantar-Zadeh K, Lochs H, Mantovani G, Marks D, Mitch WE, Muscaritoli M, Najand A, Ponikowski P, Rossi Fanelli F, Schambelan M, Schols A, Schuster M, Thomas D, Wolfe R, Anker SD (2008) Cachexia: a new definition. Clin Nutr 27(6):793–799. https://doi.org/10.1016/j.clnu.2008.06.013
Fearon K, Strasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, Davis M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE (2011) Definition and classification of cancer cachexia: an international consensus. Lancet Oncol 12(5):489–495. https://doi.org/10.1016/S1470-2045(10)70218-7
Fearon KCH, Glass DJ, Guttridge DC (2012) Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metab 16(2):153–166. https://doi.org/10.1016/j.cmet.2012.06.011
Fontes-Oliveira CC, Busquets S, Fuster G, Ametller E, Figueras M, Olivan M, Toledo M, López-Soriano FJ, Qu X, Demuth J, Stevens P, Varbanov A, Wang F, Isfort RJ, Argilés JM (2014) A differential pattern of gene expression in skeletal muscle of tumor-bearing rats reveals dysregulation of excitation-contraction coupling together with additional muscle alterations. Muscle Nerve 49(2):233–248. https://doi.org/10.1002/mus.23893
Frydelund-Larsen L, Penkowa M, Akerstrom T, Zankari A, Nielsen S, Pedersen BK (2007) Exercise induces interleukin-8 receptor (CXCR2) expression in human skeletal muscle. Exp Physiol 92(1):233–240. https://doi.org/10.1113/expphysiol.2006.034769
Gaggini M, Cabiati M, Del Turco S, Navarra T, De Simone P, Filipponi F, Del Ry S, Gastaldelli A, Basta G (2017) Increased FNDC5/Irisin expression in human hepatocellular carcinoma. Peptides 88:62–66. https://doi.org/10.1016/j.peptides.2016.12.014
Gannon NP, Vaughan RA, Garcia-Smith R, Bisoffi M, Trujillo KA (2015) Effects of the exercise-inducible myokine irisin on malignant and non-malignant breast epithelial cell behavior in vitro. Int J Cancer 136(4):E197–E202. https://doi.org/10.1002/ijc.29142
Gleeson M (2000) Interleukins and exercise. J Physiol 529(1):1–1. https://doi.org/10.1111/j.1469-7793.2000.00001.x
Golan T, Geva R, Richards D, Madhusudan S, Lin BK, Wang HT, Walgren RA, Stemmer SM (2018) LY2495655, an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial. J Cachexia Sarcopenia Muscle 9(5):871–879. https://doi.org/10.1002/jcsm.12331
Görgens SW, Raschke S, Holven KB, Jensen J, Eckardt K, Eckel J (2013) Regulation of follistatin-like protein 1 expression and secretion in primary human skeletal muscle cells. Arch Physiol Biochem 119(2):75–80. https://doi.org/10.3109/13813455.2013.768270
Gustafson MP, Wheatley-Guy CM, Rosenthal AC, Gastineau DA, Katsanis E, Johnson BD, Simpson RJ (2021) Exercise and the immune system: taking steps to improve responses to cancer immunotherapy. J Immunother Cancer 9(7):e001872. https://doi.org/10.1136/jitc-2020-001872
Hashida R, Kawaguchi T, Koya S, Hirota K, Goshima N, Yoshiyama T, Otsuka T, Bekki M, Iwanaga S, Nakano D, Niizeki T, Matsuse H, Kawaguchi A, Shiba N, Torimura T (2020) Impact of cancer rehabilitation on the prognosis of patients with hepatocellular carcinoma. Oncol Lett. https://doi.org/10.3892/ol.2020.11345
Henningsen J, Rigbolt KTG, Blagoev B, Pedersen BK, Kratchmarova I (2010) Dynamics of the skeletal muscle Secretome during myoblast differentiation. Mol Cell Proteomics 9(11):2482–2496. https://doi.org/10.1074/mcp.M110.002113
Henningsen J, Pedersen BK, Kratchmarova I (2011) Quantitative analysis of the secretion of the MCP family of chemokines by muscle cells. Mol BioSyst 7(2):311–321. https://doi.org/10.1039/C0MB00209G
Hojman P, Dethlefsen C, Brandt C, Hansen J, Pedersen L, Pedersen BK (2011) Exercise-induced muscle-derived cytokines inhibit mammary cancer cell growth. Am J Physiol Metab 301(3):E504–E510. https://doi.org/10.1152/ajpendo.00520.2010
Hojman P, Gehl J, Christensen JF, Pedersen BK (2018) Molecular mechanisms linking exercise to cancer prevention and treatment. Cell Metab 27(1):10–21. https://doi.org/10.1016/j.cmet.2017.09.015
Holland WL, Adams AC, Brozinick JT, Bui HH, Miyauchi Y, Kusminski CM, Bauer SM, Wade M, Singhal E, Cheng CC, Volk K, Kuo M-S, Gordillo R, Kharitonenkov A, Scherer PE (2013) An FGF21-adiponectin-ceramide axis controls energy expenditure and insulin action in mice. Cell Metab 17(5):790–797. https://doi.org/10.1016/j.cmet.2013.03.019
Huang C, Chang Y, Lee H, Wu J, Huang J, Chung Y, Hsu S, Chow L, Wei K, Huang F (2020) Irisin, an exercise myokine, potently suppresses tumor proliferation, invasion, and growth in glioma. FASEB J 34(7):9678–9693. https://doi.org/10.1096/fj.202000573RR
Huang Q, Wu M, Wu X, Zhang Y, Xia Y (2022) Muscle-to-tumor crosstalk: the effect of exercise-induced myokine on cancer progression. Biochim Biophys Acta – Rev Cancer 1877(5):188761. https://doi.org/10.1016/j.bbcan.2022.188761
Huh JY, Dincer F, Mesfum E, Mantzoros CS (2014) Irisin stimulates muscle growth-related genes and regulates adipocyte differentiation and metabolism in humans. Int J Obes 38(12):1538–1544. https://doi.org/10.1038/ijo.2014.42
Huot JR, Novinger LJ, Pin F, Bonetto A (2020a) HCT116 colorectal liver metastases exacerbate muscle wasting in a mouse model for the study of colorectal cancer cachexia. Dis Model Mech. https://doi.org/10.1242/dmm.043166
Huot JR, Pin F, Narasimhan A, Novinger LJ, Keith AS, Zimmers TA, Willis MS, Bonetto A (2020b) ACVR2B antagonism as a countermeasure to multi-organ perturbations in metastatic colorectal cancer cachexia. J Cachexia Sarcopenia Muscle 11(6):1779–1798. https://doi.org/10.1002/jcsm.12642
Iizuka K, Machida T, Hirafuji M (2014) Skeletal muscle is an endocrine organ. J Pharmacol Sci 125(2):125–131. https://doi.org/10.1254/jphs.14R02CP
Itoh N (2014) FGF21 as a hepatokine, adipokine, and myokine in metabolism and diseases. Front Endocrinol (Lausanne) 5. https://doi.org/10.3389/fendo.2014.00107
Je Y, Jeon JY, Giovannucci EL, Meyerhardt JA (2013) Association between physical activity and mortality in colorectal cancer: a meta-analysis of prospective cohort studies. Int J Cancer 133(8):1905–1913. https://doi.org/10.1002/ijc.28208
Ji K, Zheng J, Lv J, Xu J, Ji X, Luo Y-B, Li W, Zhao Y, Yan C (2015) Skeletal muscle increases FGF21 expression in mitochondrial disorders to compensate for energy metabolic insufficiency by activating the mTOR–YY1–PGC1α pathway. Free Radic Biol Med 84:161–170. https://doi.org/10.1016/j.freeradbiomed.2015.03.020
Joulia D, Bernardi H, Garandel V, Rabenoelina F, Vernus B, Cabello G (2003) Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res 286(2):263–275. https://doi.org/10.1016/S0014-4827(03)00074-0
Kalkan AK, Cakmak HA, Erturk M, Kalkan KE, Uzun F, Tasbulak O, Diker VO, Aydin S, Celik A (2018) Adropin and irisin in patients with cardiac cachexia. Arq Bras Cardiol. https://doi.org/10.5935/abc.20180109
Kanzleiter T, Rath M, Görgens SW, Jensen J, Tangen DS, Kolnes AJ, Kolnes KJ, Lee S, Eckel J, Schürmann A, Eckardt K (2014) The myokine decorin is regulated by contraction and involved in muscle hypertrophy. Biochem Biophys Res Commun 450(2):1089–1094. https://doi.org/10.1016/j.bbrc.2014.06.123
Kawaguchi T, Yoshio S, Sakamoto Y, Hashida R, Koya S, Hirota K, Nakano D, Yamamura S, Niizeki T, Matsuse H, Torimura T (2020) Impact of decorin on the physical function and prognosis of patients with hepatocellular carcinoma. J Clin Med 9(4):936. https://doi.org/10.3390/jcm9040936
Khan SU, Ghafoor S (2019) Myokines: discovery challenges and therapeutic impediments. J Pak Med Assoc 69(7):1014–1017
Krzystek-Korpacka M, Matusiewicz M, Diakowska D, Grabowski K, Blachut K, Kustrzeba-Wojcicka I, Banas T (2007) Impact of weight loss on circulating IL-1, IL-6, IL-8, TNF-α, VEGF-A, VEGF–C and midkine in gastroesophageal cancer patients. Clin Biochem 40(18):1353–1360. https://doi.org/10.1016/j.clinbiochem.2007.07.013
Laine A, Iyengar P, Pandita TK (2013) The role of inflammatory pathways in cancer-associated cachexia and radiation resistance. Mol Cancer Res 11(9):967–972. https://doi.org/10.1158/1541-7786.MCR-13-0189
Laurentino GC, Ugrinowitsch C, Roschel H, Aoki MS, Soares AG, Neves M, Aihara AY, da Rocha Correa Fernandes A, Tricoli V (2012) Strength training with blood flow restriction diminishes myostatin gene expression. Med Sci Sport Exerc 44(3):406–412. https://doi.org/10.1249/MSS.0b013e318233b4bc
Lee JH, Jun H-S (2019) Role of myokines in regulating skeletal muscle mass and function. Front Physiol 10. https://doi.org/10.3389/fphys.2019.00042
Li Y, Li F, Lin B, Kong X, Tang Y, Yin Y (2014) Myokine IL-15 regulates the crosstalk of co-cultured porcine skeletal muscle satellite cells and preadipocytes. Mol Biol Rep 41(11):7543–7553. https://doi.org/10.1007/s11033-014-3646-z
Li L, Huang S, Yao Y, Chen J, Li J, Xiang X, Deng J, Xiong J (2020) Follistatin-like 1 (FSTL1) is a prognostic biomarker and correlated with immune cell infiltration in gastric cancer. World J Surg Oncol 18(1):324. https://doi.org/10.1186/s12957-020-02070-9
Lim S, Choi SH, Koo BK, Kang SM, Yoon JW, Jang HC, Choi SM, Lee MG, Lee W, Shin H, Kim Y-B, Lee HK, Park KS (2012) Effects of aerobic exercise training on C1q tumor necrosis factor α-related protein isoform 5 (Myonectin): association with insulin resistance and mitochondrial DNA density in women. J Clin Endocrinol Metab 97(1):E88–E93. https://doi.org/10.1210/jc.2011-1743
Lin J, Arnold HB, Della-Fera MA, Azain MJ, Hartzell DL, Baile CA (2002) Myostatin knockout in mice increases myogenesis and decreases adipogenesis. Biochem Biophys Res Commun 291(3):701–706. https://doi.org/10.1006/bbrc.2002.6500
Lin Z, Tian H, Lam KSL, Lin S, Hoo RCL, Konishi M, Itoh N, Wang Y, Bornstein SR, Xu A, Li X (2013) Adiponectin mediates the metabolic effects of FGF21 on glucose homeostasis and insulin sensitivity in mice. Cell Metab 17(5):779–789. https://doi.org/10.1016/j.cmet.2013.04.005
Liu J, Song N, Huang Y, Chen Y (2018) Irisin inhibits pancreatic cancer cell growth via the AMPK-mTOR pathway. Sci Rep 8(1):15247. https://doi.org/10.1038/s41598-018-33229-w
Louis E, Raue U, Yang Y, Jemiolo B, Trappe S (2007) Time course of proteolytic, cytokine, and myostatin gene expression after acute exercise in human skeletal muscle. J Appl Physiol 103(5):1744–1751. https://doi.org/10.1152/japplphysiol.00679.2007
Loumaye A, de Barsy M, Nachit M, Lause P, Frateur L, van Maanen A, Trefois P, Gruson D, Thissen J-P (2015) Role of activin a and myostatin in human cancer cachexia. J Clin Endocrinol Metab 100(5):2030–2038. https://doi.org/10.1210/jc.2014-4318
Luo Y, McKeehan WL (2013) Stressed liver and muscle call on adipocytes with FGF21. Front Endocrinol (Lausanne) 4. https://doi.org/10.3389/fendo.2013.00194
Maalouf G-E, El Khoury D (2019) Exercise-induced Irisin, the fat Browning Myokine, as a potential anticancer agent. J Obes 2019:1–8. https://doi.org/10.1155/2019/6561726
Maeda S, Ogura K, Yoshida H, Kanai F, Ikenoue T, Kato N, Shiratori Y, Omata M (1998) Major virulence factors, VacA and CagA, are commonly positive in helicobacter pylori isolates in Japan. Gut 42(3):338–343. https://doi.org/10.1136/gut.42.3.338
Manole E, Ceafalan LC, Popescu BO, Dumitru C, Bastian AE (2018) Myokines as possible therapeutic targets in cancer cachexia. J Immunol Res 2018:1–9. https://doi.org/10.1155/2018/8260742
Martinelli GB, Olivari D, Re Cecconi AD, Talamini L, Ottoboni L, Lecker SH, Stretch C, Baracos VE, Bathe OF, Resovi A, Giavazzi R, Cervo L, Piccirillo R (2016) Activation of the SDF1/CXCR4 pathway retards muscle atrophy during cancer cachexia. Oncogene 35(48):6212–6222. https://doi.org/10.1038/onc.2016.153
Martínez-Hernández PL, Hernanz-Macías Á, Gómez-Candela C, Grande-Aragón C, Feliu-Batlle J, Castro-Carpeño J, Martínez-Muñoz I, Zurita-Rosa L, Villarino-Sanz M, Prados-Sánchez C, Sánchez García-Girón J (2012) Serum interleukin-15 levels in cancer patients with cachexia. Oncol Rep 28(4):1443–1452. https://doi.org/10.3892/or.2012.1928
Mashili FL, Austin RL, Deshmukh AS, Fritz T, Caidahl K, Bergdahl K, Zierath JR, Chibalin AV, Moller DE, Kharitonenkov A, Krook A (2011) Direct effects of FGF21 on glucose uptake in human skeletal muscle: implications for type 2 diabetes and obesity. Diabetes Metab Res Rev 27(3):286–297. https://doi.org/10.1002/dmrr.1177
Matsuo K, Sato K, Suemoto K, Miyamoto-Mikami E, Fuku N, Higashida K, Tsuji K, Xu Y, Liu X, Iemitsu M, Hamaoka T, Tabata I (2017) A mechanism underlying preventive effect of high-intensity training on colon cancer. Med Sci Sport Exerc 49(9):1805–1816. https://doi.org/10.1249/MSS.0000000000001312
Matsushima K, Morishita K, Yoshimura T, Lavu S, Kobayashi Y, Lew W, Appella E, Kung HF, Leonard EJ, Oppenheim JJ (1988) Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J Exp Med 167(6):1883–1893. https://doi.org/10.1084/jem.167.6.1883
Matsushima K, Baldwin ET, Mukaida N (1992) Interleukin-8 and MCAF: novel leukocyte recruitment and activating cytokines (part 2 of 2). In: Interleukins: molecular biology and immunology. KARGER, Basel, pp 251–265
McPherron AC, Lee S-J (2002) Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 109(5):595–601. https://doi.org/10.1172/JCI13562
McPherron AC, Lawler AM, Lee S-J (1997) Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member. Nature 387(6628):83–90. https://doi.org/10.1038/387083a0
Miyabe M, Ohashi K, Shibata R, Uemura Y, Ogura Y, Yuasa D, Kambara T, Kataoka Y, Yamamoto T, Matsuo K, Joki Y, Enomoto T, Hayakawa S, Hiramatsu-Ito M, Ito M, Van Den Hoff MJB, Walsh K, Murohara T, Ouchi N (2014) Muscle-derived follistatin-like 1 functions to reduce neointimal formation after vascular injury. Cardiovasc Res 103(1):111–120. https://doi.org/10.1093/cvr/cvu105
Molanouri Shamsi M, Chekachak S, Soudi S, Gharakhanlou R, Quinn LS, Ranjbar K, Rezaei S, Shirazi FJ, Allahmoradi B, Yazdi MH, Mahdavi M, Voltarelli FA (2019) Effects of exercise training and supplementation with selenium nanoparticle on T-helper 1 and 2 and cytokine levels in tumor tissue of mice bearing the 4 T1 mammary carcinoma. Nutrition 57:141–147. https://doi.org/10.1016/j.nut.2018.05.022
Nishikawa H, Enomoto H, Ishii A, Iwata Y, Miyamoto Y, Ishii N, Yuri Y, Hasegawa K, Nakano C, Nishimura T, Yoh K, Aizawa N, Sakai Y, Ikeda N, Takashima T, Takata R, Iijima H, Nishiguchi S (2017) Elevated serum myostatin level is associated with worse survival in patients with liver cirrhosis. J Cachexia Sarcopenia Muscle 8(6):915–925. https://doi.org/10.1002/jcsm.12212
Nowinska K, Jablonska K, Pawelczyk K, Piotrowska A, Partynska A, Gomulkiewicz A, Ciesielska U, Katnik E, Grzegrzolka J, Glatzel-Plucinska N, Ratajczak-Wielgomas K (2019) Expression of Irisin/FNDC5 in cancer cells and stromal fibroblasts of non-small cell lung cancer. Cancers (Basel) 11(10):1538. https://doi.org/10.3390/cancers11101538
Okita K, Kinugawa S, Tsutsui H (2013) Exercise intolerance in chronic heart failure. Circ J 77(2):293–300. https://doi.org/10.1253/circj.CJ-12-1235
Ouchi N, Oshima Y, Ohashi K, Higuchi A, Ikegami C, Izumiya Y, Walsh K (2008) Follistatin-like 1, a secreted muscle protein, promotes endothelial cell function and revascularization in ischemic tissue through a nitric-oxide synthase-dependent mechanism. J Biol Chem 283(47):32802–32811. https://doi.org/10.1074/jbc.M803440200
Papadopetraki A, Maridaki M, Zagouri F, Dimopoulos M-A, Koutsilieris M, Philippou A (2022) Physical exercise restrains cancer progression through muscle-derived factors. Cancers (Basel) 14(8):1892. https://doi.org/10.3390/cancers14081892
Park S-Y, Choi JH, Ryu HS, Pak YK, Park KS, Lee HK, Lee W (2009) C1q tumor necrosis factor α-related protein isoform 5 is increased in mitochondrial DNA-depleted myocytes and activates AMP-activated protein kinase. J Biol Chem 284(41):27780–27789. https://doi.org/10.1074/jbc.M109.005611
Pedersen BK (2011) Muscles and their myokines. J Exp Biol 214(2):337–346. https://doi.org/10.1242/jeb.048074
Pedersen BK, Febbraio MA (2008) Muscle as an endocrine organ: focus on muscle-derived interleukin-6. Physiol Rev 88(4):1379–1406. https://doi.org/10.1152/physrev.90100.2007
Pedersen BK, Febbraio MA (2012) Muscles, exercise and obesity: skeletal muscle as a secretory organ. Nat Rev Endocrinol 8(8):457–465. https://doi.org/10.1038/nrendo.2012.49
Pedersen L, Hojman P (2012) Muscle-to-organ cross talk mediated by myokines. Adipocytes 1(3):164–167. https://doi.org/10.4161/adip.20344
Pedersen BK, Åkerström TCA, Nielsen AR, Fischer CP (2007) Role of myokines in exercise and metabolism. J Appl Physiol 103(3):1093–1098. https://doi.org/10.1152/japplphysiol.00080.2007
Pedersen L, Idorn M, Olofsson GH, Lauenborg B, Nookaew I, Hansen RH, Johannesen HH, Becker JC, Pedersen KS, Dethlefsen C, Nielsen J (2016) Voluntary running suppresses tumor growth through epinephrine- and IL-6-dependent NK cell mobilization and redistribution. Cell Metab 23(3):554–562. https://doi.org/10.1016/j.cmet.2016.01.011
Penna F, Ballarò R, Beltrà M, De Lucia S, García Castillo L, Costelli P (2019) The skeletal muscle as an active player against cancer cachexia. Front Physiol 10. https://doi.org/10.3389/fphys.2019.00041
Pettersen K, Andersen S, Degen S, Tadini V, Grosjean J, Hatakeyama S, Tesfahun AN, Moestue S, Kim J, Nonstad U, Romundstad PR, Skorpen F, Sørhaug S, Amundsen T, Grønberg BH, Strasser F, Stephens N, Hoem D, Molven A, Kaasa S, Fearon K, Jacobi C, Bjørkøy G (2017) Cancer cachexia associates with a systemic autophagy-inducing activity mimicked by cancer cell-derived IL-6 trans-signaling. Sci Rep 7(1):2046. https://doi.org/10.1038/s41598-017-02088-2
Pfitzenmaier J, Vessella R, Higano CS, Noteboom JL, Wallace D, Corey E (2003) Elevation of cytokine levels in cachectic patients with prostate carcinoma. Cancer 97(5):1211–1216. https://doi.org/10.1002/cncr.11178
Pin F, Barreto R, Kitase Y, Mitra S, Erne CE, Novinger LJ, Zimmers TA, Couch ME, Bonewald LF, Bonetto A (2018a) Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia. J Cachexia Sarcopenia Muscle 9(4):685–700. https://doi.org/10.1002/jcsm.12311
Pin F, Couch ME, Bonetto A (2018b) Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition. Curr Opin Support Palliat Care 12(4):420–426. https://doi.org/10.1097/SPC.0000000000000382
Pin F, Bonewald LF, Bonetto A (2021) Role of myokines and osteokines in cancer cachexia. Exp Biol Med 246(19):2118–2127. https://doi.org/10.1177/15353702211009213
Pistilli EE, Alway SE (2008) Systemic elevation of interleukin-15 in vivo promotes apoptosis in skeletal muscles of young adult and aged rats. Biochem Biophys Res Commun 373(1):20–24. https://doi.org/10.1016/j.bbrc.2008.05.188
Provatopoulou X, Georgiou GP, Kalogera E, Kalles V, Matiatou MA, Papapanagiotou I, Sagkriotis A, Zografos GC, Gounaris A (2015) Serum irisin levels are lower in patients with breast cancer: association with disease diagnosis and tumor characteristics. BMC Cancer 15(1):898. https://doi.org/10.1186/s12885-015-1898-1
Quinn LS, Anderson BG, Drivdahl RH, Alvarez B, Argilés JM (2002) Overexpression of interleukin-15 induces skeletal muscle hypertrophy in vitro: implications for treatment of muscle wasting disorders. Exp Cell Res 280(1):55–63. https://doi.org/10.1006/excr.2002.5624
Re Cecconi AD, Forti M, Chiappa M, Zhu Z, Zingman LV, Cervo L, Beltrame L, Marchini S, Piccirillo R (2019) Musclin, a myokine induced by aerobic exercise, retards muscle atrophy during cancer cachexia in mice. Cancers (Basel) 11(10):1541. https://doi.org/10.3390/cancers11101541
Reszegi A, Horváth Z, Fehér H, Wichmann B, Tátrai P, Kovalszky I, Baghy K (2020) Protective role of decorin in primary hepatocellular carcinoma. Front Oncol 10. https://doi.org/10.3389/fonc.2020.00645
Reza MM, Sim CM, Subramaniyam N, Ge X, Sharma M, Kambadur R, McFarlane C (2017) Irisin treatment improves healing of dystrophic skeletal muscle. Oncotarget 8(58):98553–98566. https://doi.org/10.18632/oncotarget.21636
Ruas JL, White JP, Rao RR, Kleiner S, Brannan KT, Harrison BC, Greene NP, Wu J, Estall JL, Irving BA, Lanza IR, Rasbach KA, Okutsu M, Nair KS, Yan Z, Leinwand LA, Spiegelman BM (2012) A PGC-1α isoform induced by resistance training regulates skeletal muscle hypertrophy. Cell 151(6):1319–1331. https://doi.org/10.1016/j.cell.2012.10.050
Sah RP, Sharma A, Nagpal S, Patlolla SH, Sharma A, Kandlakunta H, Anani V, Angom RS, Kamboj AK, Ahmed N, Mohapatra S, Vivekanandhan S, Philbrick KA, Weston A, Takahashi N, Kirkland J, Javeed N, Matveyenko A, Levy MJ, Mukhopadhyay D, Chari ST (2019) Phases of metabolic and soft tissue changes in months preceding a diagnosis of pancreatic ductal adenocarcinoma. Gastroenterology 156(6):1742–1752. https://doi.org/10.1053/j.gastro.2019.01.039
Sainio AO, Järveläinen HT (2019) Decorin-mediated oncosuppression – a potential future adjuvant therapy for human epithelial cancers. Br J Pharmacol 176(1):5–15. https://doi.org/10.1111/bph.14180
Santana Carrero RM, Beceren-Braun F, Rivas SC, Hegde SM, Gangadharan A, Plote D, Pham G, Anthony SM, Schluns KS (2019) IL-15 is a component of the inflammatory milieu in the tumor microenvironment promoting antitumor responses. Proc Natl Acad Sci 116(2):599–608. https://doi.org/10.1073/pnas.1814642116
Schnyder S, Handschin C (2015) Skeletal muscle as an endocrine organ: PGC-1α, myokines and exercise. Bone 80:115–125. https://doi.org/10.1016/j.bone.2015.02.008
Schuelke M, Wagner KR, Stolz LE, Hübner C, Riebel T, Kömen W, Braun T, Tobin JF, Lee S-J (2004) Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 350(26):2682–2688. https://doi.org/10.1056/NEJMoa040933
Seldin MM, Wong GW (2012) Regulation of tissue crosstalk by skeletal muscle-derived myonectin and other myokines. Adipocytes 1(4):200–202. https://doi.org/10.4161/adip.20877
Seldin MM, Peterson JM, Byerly MS, Wei Z, Wong GW (2012) Myonectin (CTRP15), a novel Myokine that links skeletal muscle to systemic lipid homeostasis. J Biol Chem 287(15):11968–11980. https://doi.org/10.1074/jbc.M111.336834
Seldin MM, Lei X, Tan SY, Stanson KP, Wei Z, Wong GW (2013) Skeletal muscle-derived myonectin activates the mammalian target of rapamycin (mTOR) pathway to suppress autophagy in liver. J Biol Chem 288(50):36073–36082. https://doi.org/10.1074/jbc.M113.500736
Serrano AL, Baeza-Raja B, Perdiguero E, Jardí M, Muñoz-Cánoves P (2008) Interleukin-6 is an essential regulator of satellite cell-mediated skeletal muscle hypertrophy. Cell Metab 7(1):33–44. https://doi.org/10.1016/j.cmet.2007.11.011
Severinsen MCK, Pedersen BK (2020) Muscle–organ crosstalk: the emerging roles of myokines. Endocr Rev 41(4):594–609. https://doi.org/10.1210/endrev/bnaa016
Stewart GD, Skipworth RJ, Fearon KC (2006) Cancer cachexia and fatigue. Clin Med 6(2):140–143. https://doi.org/10.7861/clinmedicine.6-2-140
Stolz LE, Li D, Qadri A, Jalenak M, Klaman LD, Tobin JF (2006) Administration of myostatin does not alter fat mass in adult mice. Diabetes Obes Metab 10:135–142. https://doi.org/10.1111/j.1463-1326.2006.00672.x
Strassmann G, Fong M, Kenney JS, Jacob CO (1992) Evidence for the involvement of interleukin 6 in experimental cancer cachexia. J Clin Invest 89(5):1681–1684. https://doi.org/10.1172/JCI115767
Subbotina E, Sierra A, Zhu Z, Gao Z, Koganti SRK, Reyes S, Stepniak E, Walsh SA, Acevedo MR, Perez-Terzic CM, Hodgson-Zingman DM, Zingman LV (2015) Musclin is an activity-stimulated myokine that enhances physical endurance. Proc Natl Acad Sci 112(52):16042–16047. https://doi.org/10.1073/pnas.1514250112
Szalay K, Rázga Z, Duda E (1997) TNF inhibits myogenesis and downregulates the expression of myogenic regulatory factors myoD and myogenin. Eur J Cell Biol 74(4):391–398
Tan BH, Fearon KC (2008) Cachexia: prevalence and impact in medicine. Curr Opin Clin Nutr Metab Care 11(4):400–407. https://doi.org/10.1097/MCO.0b013e328300ecc1
Teicher BA, Fricker SP (2010) CXCL12 (SDF-1)/CXCR4 pathway in cancer. Clin Cancer Res 16(11):2927–2931. https://doi.org/10.1158/1078-0432.CCR-09-2329
Tisdale MJ (2009) Mechanisms of cancer cachexia. Physiol Rev 89(2):381–410. https://doi.org/10.1152/physrev.00016.2008
Trayhurn P, Drevon CA, Eckel J (2011) Secreted proteins from adipose tissue and skeletal muscle – adipokines, myokines and adipose/muscle cross-talk. Arch Physiol Biochem 117(2):47–56. https://doi.org/10.3109/13813455.2010.535835
Trendelenburg AU, Meyer A, Rohner D, Boyle J, Hatakeyama S, Glass DJ (2009) Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size. Am J Physiol Physiol 296(6):C1258–C1270. https://doi.org/10.1152/ajpcell.00105.2009
Us Altay D, Keha EE, Ozer Yaman S, Ince I, Alver A, Erdogan B, Canpolat S, Cobanoglu U, Mentese A (2016) Investigation of the expression of irisin and some cachectic factors in mice with experimentally induced gastric cancer. QJM 109(12):785–790. https://doi.org/10.1093/qjmed/hcw074
von Haehling S, Anker SD (2010) Cachexia as a major underestimated and unmet medical need: facts and numbers. J Cachexia Sarcopenia Muscle 1(1):1–5. https://doi.org/10.1007/s13539-010-0002-6
Wang M, Yu H, Kim YS, Bidwell CA, Kuang S (2012) Myostatin facilitates slow and inhibits fast myosin heavy chain expression during myogenic differentiation. Biochem Biophys Res Commun 426(1):83–88. https://doi.org/10.1016/j.bbrc.2012.08.040
White JP, Puppa MJ, Sato S, Gao S, Price RL, Baynes JW, Kostek MC, Matesic LE, Carson JA (2012) IL-6 regulation on skeletal muscle mitochondrial remodeling during cancer cachexia in the Apc Min/+ mouse. Skelet Muscle 2(1):14. https://doi.org/10.1186/2044-5040-2-14
Yu P, Steel JC, Zhang M, Morris JC, Waldmann TA (2010) Simultaneous blockade of multiple immune system inhibitory checkpoints enhances antitumor activity mediated by Interleukin-15 in a murine metastatic colon carcinoma model. Clin Cancer Res 16(24):6019–6028. https://doi.org/10.1158/1078-0432.CCR-10-1966
Zhang Z, Zhang X, Li H, Liu T, Zhao Q, Huang L, Cao Z, He L, Hao D (2018) Serum irisin associates with breast cancer to spinal metastasis. Medicine (Baltimore) 97(17):e0524. https://doi.org/10.1097/MD.0000000000010524
Zhang D, Tan X, Tang N, Huang F, Chen Z, Shi G (2020) Review of research on the role of irisin in tumors. Onco Targets Ther 13:4423–4430. https://doi.org/10.2147/OTT.S245178
Zhu H, Liu M, Zhang N, Pan H, Lin G, Li N, Wang L, Yang H, Yan K, Gong F (2018) Serum and adipose tissue mRNA levels of ATF3 and FNDC5/Irisin in colorectal cancer patients with or without obesity. Front Physiol 9. https://doi.org/10.3389/fphys.2018.01125
Zimmers TA, Davies MV, Koniaris LG, Haynes P, Esquela AF, Tomkinson KN, McPherron AC, Wolfman NM, Lee S-J (2002) Induction of cachexia in mice by systemically administered myostatin. Science 296(5572):1486–1488. https://doi.org/10.1126/science.1069525
Disclosure of Potential Conflicts of Interest
The authors declare no conflict of interest.
Acknowledgments and Funding Information
Funding This work was funded by Ministry of Research, Innovation and Digitalization in Romania, under Program 1 – The Improvement of the National System of Research and Development, Subprogram 1.2 – Institutional Excellence-Projects of Excellence Funding in RDI, Contract No. 31PFE/30.12.2021 and the National Program 1 N/2019/PN 19.29.02.01.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Manole, E., Ceafalan, L.C., Gaina, G.F., Mosoia, O.A., Hinescu, M.E. (2023). Myokine Expression in Cancer Cachexia. In: Rezaei, N. (eds) Cancer Research: An Interdisciplinary Approach. Interdisciplinary Cancer Research, vol 1. Springer, Cham. https://doi.org/10.1007/16833_2023_138
Download citation
DOI: https://doi.org/10.1007/16833_2023_138
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-32457-4
Online ISBN: 978-3-031-32458-1
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)